Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / September / Autopsy Study Assesses Seaport Criteria
Forensics Biochemistry and molecular biology

Autopsy Study Assesses Seaport Criteria

Researchers applied Seaport criteria to 93 autopsy cases, assessing classification and sampling adherence

09/19/2025 News 2 min read
article Full Article Summary Notecard

Share

Credit: Original image sourced from Adobe Stock

Applying the Seaport criteria to 93 autopsy hearts yielded 36 diffuse, 27 multifocal, and 2 focal myocarditis, plus 28 lymphocytic infiltrates of unknown significance, according to a recent study.

Researchers evaluated the practical applicability of the Seaport criteria for diagnosing lymphocytic myocarditis in autopsy hearts. In a retrospective review of 93 forensic autopsies with lymphocyte-predominant myocardial inflammation, the criteria were applied to reclassify the extent of inflammation and to compare results with recorded causes of death. The study, published in Cardiovascular Pathology, also assessed adherence to minimum technical sampling requirements and the content of original histology reports.

The Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology finalized the Seaport criteria in March 2025 for non-biopsy specimens. The cohort included cases in which myocarditis was listed as the cause of death (45), an unascertained cause of death (34), or drug toxicity (14). Most cases met the minimum sampling standard of at least six full-thickness ventricular sections across five or six blocks (76 of 93, or 82 percent). Pediatric cases were disproportionately noncompliant, reflecting smaller heart size and fewer blocks despite sampling of the prescribed regions. A mid-ventricular short-axis section was retained in 58 cases, and additional tissue was submitted in 13.

Among deaths attributed to myocarditis, 9 were multifocal and 3 were lymphocytic infiltrates of unknown significance (LIUS); in the unascertained cohort, diagnoses included 1 diffuse, 16 multifocal, 2 focal, and 15 LIUS (with one focal case adjacent to the atrioventricular node and LIUS elsewhere). In drug-related deaths, diagnoses included 2 diffuse, 2 multifocal, and 10 LIUS.

Original histology narratives varied in terminology and detail. Only a minority documented the presence or absence of myocyte injury, and descriptions of extent were often brief and imprecise. Evidence of chronicity was explicitly described in three cases. Classification was performed using the highest applicable grade when prerequisites were met. Recognition of myocyte injury was sometimes difficult and, in dense infiltrates, could be obscured.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Biochemistry and molecular biology
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

Molecular Spectacular
Biochemistry and molecular biology
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

qPCR Infectious Disease Detective
Biochemistry and molecular biology
qPCR: Infectious Disease Detective

January 4, 2024

3 min read

How quantitative polymerase chain reaction really hits the mark in epidemic control and ID detection

Case of the Month
Biochemistry and molecular biology
Case of the Month

January 11, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.